Ultrafiltration rate adjusted to body weight and mortality in hemodialysis patients

Background and aims: Mortality among hemodialysis patients remains high. An elevated ultrafiltration rate adjusted by weight (UFR/W) has been associated with hypotension and higher risk of death and/or cardiovascular events. Methods: We evaluated the association between UFR/W and mortality in 215 he...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nefrología 2021-07, Vol.41 (4), p.426-435
Hauptverfasser: Fernandez-Prado, Raul, Pena-Esparragoza, Jessy Korina, Santos-Sanchez-Rey, Begona, Avello, Alejandro, Goma-Garces, Elena, Gonzalez-Rivera, Marina, Gonzalez-Martin, Guillermo, Gracia-Iguacel, Carolina, Mahillo, Ignacio, Ortiz, Alberto, Gonzalez-Parra, Emilio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and aims: Mortality among hemodialysis patients remains high. An elevated ultrafiltration rate adjusted by weight (UFR/W) has been associated with hypotension and higher risk of death and/or cardiovascular events. Methods: We evaluated the association between UFR/W and mortality in 215 hemodialysis patients. The mean follow-up was 28 +/- 6.12 months. We collected patients' baseline characteristics and mean UFR/W throughout the follow-up. Results: Mean UFR/W was 9.0 +/- 2,4 and tertiles 7.1 y 10.1 mL/kg/h. We divided our population according to the percentage of sessions with UFR/W above the limits described in the literature associated with increased mortality (10.0 ml/kg/h and 13.0 mL/kg/h). Patients with higher UFR/W were younger, with higher interdialytic weight gain and weight reduction percentage but lower dry, pre and post dialysis weight. Throughout the follow-up, 46 (21.4%) patients died, the majority over 70 years old, diabetic or with cardiovascular disease. There were neither differences regarding mortality between groups nor differences in UFR/W among patients who died and those who did not. Contrary to previous studies, we did not find an association between UFR/W and mortality, maybe due to a higher prevalence in the use of cardiovascular protection drugs and lower UFR/W. Conclusions: The highest UFR/W were observed in younger patients with lower weight and were not associated with an increased mortality. (C) 2021 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U.
ISSN:0211-6995
1989-2284
DOI:10.1016/j.nefro.2020.10.007